Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperuricosuric calcium nephrolithiasis.

Carsten M Sorensen1, Paramjit S Chandhoke

  • 1Division of Urology, University of Colorado Health Sciences Center, 4200 East 9th Avenue, Box C-319, Denver, CO 80262, USA.

Endocrinology and Metabolism Clinics of North America
|December 12, 2002
PubMed
Summary

Hyperuricosuria, a condition of high uric acid in urine, is linked to calcium oxalate stones. Allopurinol effectively reduces stone recurrence in patients with hypercalciuria and hyperuricosuria (HCN).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Editorial Comment on:</i> "Integrated, Real-Time Digital Measurement During Ureteroscopic Procedures for Nephrolithiasis: A Workflow Feasibility Study" by Koo et al.

Journal of endourology·2020
Same author

Evaluation of the recurrent stone former.

The Urologic clinics of North America·2007
Same author

Betamethasone cream for the treatment of pre-pubertal labial adhesions.

Journal of pediatric and adolescent gynecology·2006
Same author

Does a slower treatment rate impact the efficacy of extracorporeal shock wave lithotripsy for solitary kidney or ureteral stones?

The Journal of urology·2006
Same author

Oxalate toxicity in cultured mouse inner medullary collecting duct cells.

The Journal of urology·2005
Same author

Gender Differences among Hispanics and Caucasians in symptomatic presentation of kidney and ureteral stones.

Journal of endourology·2005

Area of Science:

  • Nephrology
  • Urology
  • Biochemistry

Background:

  • Hyperuricosuria is a recognized risk factor for calcium urolithiasis.
  • The precise mechanism linking uric acid to calcium oxalate crystallization remains unclear.
  • Isolated hypercalciuria (HCN) is a distinct clinical entity.

Purpose of the Study:

  • To elucidate the physicochemical mechanism of uric acid's effect on calcium oxalate crystallization.
  • To review the role of hyperuricosuria in calcium stone formation.
  • To highlight allopurinol's efficacy in managing stone recurrences.

Main Methods:

  • Literature review of clinical and epidemiologic studies.
  • Analysis of physicochemical mechanisms.
  • Clinical data on allopurinol treatment outcomes.

Related Experiment Videos

Main Results:

  • Numerous studies suggest hyperuricosuria contributes to calcium stone formation.
  • The exact physicochemical pathway is not yet definitively proven.
  • Allopurinol has demonstrated a reduction in stone recurrence rates.

Conclusions:

  • Hyperuricosuric calcium stone formers represent a unique patient group.
  • Further research is needed to fully understand the uric acid-calcium oxalate interaction.
  • Allopurinol is a key therapeutic agent for patients with hypercalciuria and hyperuricosuria.